5,11-Dihydro-11-[4-(1-piperidinyl)-but-2-ynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one → 5,11-Dihydro-11-[4-(1-piperidinyl)butyl]-6H-pyrido[2,3-b][l,4]benzodiazepin-6-one
Reaction equation
[N:1]1([CH2:7][C:8]#[C:9][CH2:10][N:11]2[C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=3[C:15](=[O:22])[NH:14][C:13]3[CH:23]=[CH:24][CH:25]=[N:26][C:12]2=3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1>C(OCC)(=O)C>[N:1]1([CH2:7][CH2:8][CH2:9][CH2:10][N:11]2[C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=3[C:15](=[O:22])[NH:14][C:13]3[CH:23]=[CH:24][CH:25]=[N:26][C:12]2=3)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1Participants
3
Procedure
Prepared analogously to Example 8 from 5,11-dihydro-11-[4-(1-piperidinyl)-but-2-ynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one in a yield of 35% of theory. Colourless crystals, m.p. 131°-132° C. (ethyl acetate).
Sources & evidence
- ORD record
- ord-ca07fb1ce11140b19bd4b6c1c1513129
- Source dataset
- uspto-grants-1991_04
- Patent number
- US05006522
Reaction notes
Loading…